|Mr. Charles Bachtell||Co-Founder, CEO & Director||663.7k||N/A||1978|
|Mr. Kenneth Edward Amann||Advisor||378.3k||482.75k||1971|
|Mr. Thomas J. Manning||Exec. Chairman||N/A||N/A||1956|
|Mr. Dominic Anthony Sergi||Co-Founder & Independent Director||N/A||N/A||1983|
|Mr. Robert M. Sampson||Co-Founder & Director||N/A||N/A||1974|
|Mr. Dennis M. Olis||Chief Financial Officer||N/A||N/A||1963|
|Mr. David Ellis||Chief Operating Officer||N/A||N/A||1982|
|Ms. Brenna Albert CPA||Sr. VP & Controller of Accounting, Treasury & Tax||N/A||N/A||N/A|
|Mr. Mo Dastagir||Chief Information Officer||N/A||N/A||1977|
|Mr. John Schetz||Gen. Counsel||N/A||N/A||1976|
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells medical cannabis and medical cannabis products in the United States. It offers cannabis in flowers, live concentrates, and liquid live resins under the Cresco and Reserve brands; soft gels, tinctures, and lotions under the Remedi brand; gummies, fruit chews, hard sweets, and chocolates under the Mindy's brand; and vape pens, popcorn, shake, pre-rolls, and shorties under High supply brand. It operates 22 dispensaries in Illinois, Pennsylvania, Ohio, California, Nevada, Arizona, Massachusetts, and New York. The company is headquartered in Chicago, Illinois.
Cresco Labs Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.